- A clinical isolate of Klebsiella pneumoniae shows resistance to ceftriaxone and ceftazidime. A combination disk test reveals that the zone of inhibition for ceftazidime increases by >5 mm when tested with clavulanic acid. The isolate remains resistant to cefoxitin. What is the most likely mechanism of beta-lactam resistance in this isolate?
Answer: Production of an extended-spectrum beta-lactamase (ESBL).
The key finding is the synergy between ceftazidime and clavulanic acid, which is the classic phenotypic definition of an ESBL. ESBLs hydrolyze extended-spectrum cephalosporins (like ceftriaxone and ceftazidime) and are inhibited by clavulanic acid. AmpC beta-lactamases (B) are not inhibited by clavulanic acid and typically confer resistance to cefoxitin. KPC carbapenemases (C) would confer resistance to carbapenems (not tested here), and while some are inhibited by clavulanate, the overall pattern is more typical for an ESBL. Porin mutations (D) would not show synergy with clavulanic acid.
- The emergence of New Delhi metallo-beta-lactamase-1 (NDM-1) is a major public health concern. An isolate of Providencia stuartii is found to harbor the blaNDM-1 gene. Which of the following characteristics is most responsible for the rapid, global dissemination of NDM-1?
Answer: The blaNDM-1 gene is typically located on highly mobile plasmids that can transfer between different bacterial species.
The primary driver for the rapid and widespread dissemination of antibiotic resistance genes like blaNDM-1 is their association with mobile genetic elements, particularly conjugative plasmids. These plasmids can transfer not only between cells of the same species but also across different species and genera (e.g., from E. coli to K. pneumoniae), facilitating rapid spread in diverse bacterial populations and geographic locations. NDM-1 provides broad resistance, not just to carbapenems (A), and it is a Class B enzyme, not Class D (C). Its mobility, not stable chromosomal inheritance (D), explains its rapid emergence.
- Two strains of Klebsiella pneumoniae carry a gene for a SHV-type beta-lactamase. In Strain A, the gene is on a high-copy-number plasmid. In Strain B, a single copy is integrated into the chromosome under the control of a weak, constitutive promoter. Which of the following would be the most likely observation when comparing the two strains in the absence of antibiotics?
Answer: Strain A will have a higher basal level of beta-lactamase expression and a higher penicillin MIC than Strain B.
The level of gene expression is critical for the resistance phenotype. A high-copy-number plasmid results in a gene dosage effect, leading to significantly more mRNA transcripts and thus more enzyme protein being produced compared to a single chromosomal copy. This higher basal level of enzyme in Strain A will lead to more efficient drug degradation and a correspondingly higher Minimum Inhibitory Concentration (MIC). Both are described as having constitutive promoters. While plasmid loss (C) can occur, the direct and certain effect on phenotype is the difference in expression level.
- A Pseudomonas aeruginosa isolate from a cystic fibrosis patient has the following MICs: Piperacillin/Tazobactam >256/4 µg/mL, Ceftazidime >64 µg/mL, Ceftazidime/Avibactam 16 µg/mL, Meropenem 16 µg/mL, Aztreonam 8 µg/mL. Which combination of resistance mechanisms is most consistent with this antibiogram?
Answer: Production of a metallo-beta-lactamase (MBL) and active efflux pump overexpression.
The key features are resistance to a carbapenem (meropenem) and retained susceptibility to aztreonam. This pattern is pathognomonic for a metallo-beta-lactamase (MBL, Ambler Class B), as MBLs hydrolyze all beta-lactams including carbapenems except for the monobactam aztreonam. KPC (D) and most ESBLs (A) would be expected to hydrolyze aztreonam. Avibactam does not inhibit MBLs, which is consistent with the ceftazidime/avibactam MIC remaining elevated. Efflux pumps commonly contribute to the high-level resistance observed in P. aeruginosa.
- Avibactam is a diazabicyclooctane beta-lactamase inhibitor that restores the activity of ceftazidime against many resistant Gram-negative bacteria. A bacterial isolate that possesses a beta-lactamase that is NOT inhibited by avibactam is identified. This enzyme is most likely a(n):
Answer: NDM-1 (a metallo-beta-lactamase).
Avibactam has a broad spectrum of activity against serine beta-lactamases, including Class A enzymes (like ESBLs and KPC carbapenemases) and Class C enzymes (AmpC). However, it is completely ineffective against Class B enzymes, the metallo-beta-lactamases (MBLs) like NDM-1, VIM, and IMP. MBLs use a zinc-dependent mechanism for hydrolysis, which is fundamentally different from the serine-based mechanism targeted by avibactam. Therefore, resistance to a ceftazidime-avibactam combination strongly suggests the presence of an MBL.
- A strain of Staphylococcus aureus acquires a plasmid containing the catA gene, conferring resistance to chloramphenicol. What is the direct biochemical consequence of the CatA protein expression?
Answer: The enzyme transfers an acetyl group from acetyl-CoA to chloramphenicol's hydroxyl groups, preventing ribosomal binding.
The cat genes encode for chloramphenicol acetyltransferase (CAT). This enzyme uses acetyl-CoA as a cofactor to transfer an acetyl group to one or both of the hydroxyl groups on the chloramphenicol molecule. This structural modification prevents the drug from binding to its target, the peptidyl transferase center of the 50S ribosomal subunit.
- A rapid test for beta-lactamase detection uses the chromogenic cephalosporin nitrocefin. When a beta-lactamase-producing bacterial colony is applied, the nearly colorless substrate solution turns red. What is the biochemical event that directly causes this color change?
Answer: Hydrolysis of the beta-lactam ring disrupts the molecule's electron conjugation system, creating a colored product.
The color change of nitrocefin is intrinsic to the molecule's structure. In its intact form, it has a specific system of conjugated double bonds that absorbs light outside the visible spectrum (appearing yellowish). When a beta-lactamase hydrolyzes the amide bond in the beta-lactam ring, the ring opens. This cleavage causes a rearrangement of the molecule's electronic structure, extending the system of conjugation. This altered conjugated system now absorbs light in the visible range, causing the compound to appear red. The event is a direct result of enzymatic bond cleavage, not just binding (A), reduction (C), or an external pH indicator (D).
- A patient with a large abscess is infected with a bacterium producing a TEM-1 beta-lactamase. Standard susceptibility testing using an inoculum of 5×105 CFU/mL shows the isolate is susceptible to piperacillin. However, the patient's therapy with piperacillin fails. What is the most likely enzymatic explanation for this therapeutic failure?
Answer: The high bacterial density in the abscess led to a high concentration of beta-lactamase, hydrolyzing the piperacillin.
This scenario describes the 'inoculum effect.' The concentration of bacteria in an infection site like an abscess can be much higher (e.g., 108 to 109 CFU/g) than the standard inoculum used for in vitro testing. This high bacterial load produces a correspondingly high concentration of beta-lactamase enzyme in the local environment. This large amount of enzyme can overwhelm the administered antibiotic, hydrolyzing it faster than it can act, leading to therapeutic failure despite in vitro susceptibility at standard inocula. - A multidrug-resistant Acinetobacter baumannii isolate is found to be resistant to imipenem. Phenotypic testing shows that its carbapenemase activity is not inhibited by either EDTA or clavulanic acid. Based on these findings, the carbapenemase most likely belongs to which Ambler class?
Answer: Class D
Carbapenemase classes are differentiated by their inhibitor profiles. Class A carbapenemases (e.g., KPC) are often inhibited by clavulanic acid. Class B enzymes are metallo-beta-lactamases and are inhibited by the chelating agent EDTA. Class C enzymes (AmpC) are typically not potent carbapenemases. Class D enzymes, the OXA-type carbapenemases, are serine-based but are characteristically not inhibited by either clavulanic acid or EDTA. OXA-type carbapenemases are very common in Acinetobacter baumannii.
- A novel beta-lactamase inhibitor is found to bind irreversibly to the active site of a TEM-1 beta-lactamase only after the enzyme initiates catalysis on the inhibitor molecule. This inhibitor shows a high affinity for the enzyme but is turned over very slowly. How would this inhibitor be best classified based on its kinetic properties?
Answer: A mechanism-based inactivator, or 'suicide inhibitor'.
The description perfectly matches that of a mechanism-based inactivator, also known as a suicide inhibitor. The enzyme binds the inhibitor as if it were a substrate, and the catalytic mechanism itself converts the inhibitor into a reactive species that then covalently and irreversibly inactivates the enzyme. This is the mechanism of action for inhibitors like clavulanic acid. A high Ki (A) indicates low affinity. The inhibitor binds to the active site, not an allosteric site (B). - An E. coli isolate is resistant to amoxicillin-clavulanate. Genetic analysis reveals it produces a TEM-1 beta-lactamase, which is normally susceptible to clavulanate. Which of the following is the most plausible additional mechanism accounting for the observed resistance?
Answer: A mutation in the TEM-1 active site that reduces affinity for clavulanate while maintaining penicillinase activity.
When an organism producing a typically inhibitor-susceptible enzyme becomes resistant to the inhibitor combination, one must consider mechanisms of inhibitor resistance. Point mutations in the active site of the TEM enzyme can lead to the formation of an inhibitor-resistant TEM (IRT) beta-lactamase. These mutations selectively decrease the binding affinity of the inhibitor (clavulanate) without significantly compromising the enzyme's ability to hydrolyze the substrate (amoxicillin). While hyperproduction (C) is also a valid mechanism, specific mutational changes conferring inhibitor resistance are a well-described and direct cause for this phenotype.
- An Escherichia coli isolate is resistant to gentamicin and tobramycin but remains susceptible to amikacin. Analysis reveals the presence of an aminoglycoside nucleotidyltransferase (ANT). Which statement best explains this resistance pattern?
Answer: Steric hindrance from amikacin's L-hydroxyaminobutyryl amide (L-HABA) side chain prevents the ANT from modifying the drug.
Aminoglycoside resistance is often due to enzymatic modification. Many common modifying enzymes (acetyltransferases, phosphotransferases, nucleotidyltransferases) are unable to bind and modify amikacin due to the bulky L-HABA side chain attached to the N1 position. This side chain provides steric protection, preserving amikacin's activity against organisms that produce such enzymes. The enzyme modifies the drug to prevent ribosomal binding, it doesn't hydrolyze it (D). ANT enzymes add nucleotide groups, not acetyl (A) or phosphate (B) groups.
- Two carbapenem-resistant K. pneumoniae isolates are being investigated. Isolate 1 is highly resistant to both ertapenem and meropenem. Isolate 2 is highly resistant to ertapenem but shows only low-level resistance to meropenem. Furthermore, Isolate 2 is highly resistant to temocillin. Which of the following is the most likely identity of the carbapenemases?
Answer: Isolate 1: KPC; Isolate 2: OXA-48
KPC (a Class A carbapenemase) typically confers high-level resistance to all carbapenems, including ertapenem and meropenem, matching Isolate 1. OXA-48 (a Class D carbapenemase) has a distinctive hydrolysis profile: it is a potent ertapenemase but hydrolyzes imipenem and meropenem much more weakly. This leads to the characteristic phenotype of high-level ertapenem resistance with much lower-level resistance to other carbapenems, matching Isolate 2. High-level resistance to temocillin is also a hallmark of OXA-48-like enzymes.
- An unknown beta-lactamase is purified from a clinical isolate of Pseudomonas aeruginosa. It is shown to efficiently hydrolyze cefepime and meropenem but has minimal activity against aztreonam. The enzyme's activity is significantly reduced in the presence of dipicolinic acid. This enzyme is most likely a(n):
Answer: Metallo-beta-lactamase (MBL).
This profile is characteristic of a metallo-beta-lactamase (MBL, Class B). MBLs have a broad substrate profile that includes carbapenems (meropenem) and advanced-generation cephalosporins (cefepime). A key identifying feature is their inability to hydrolyze the monobactam aztreonam. Furthermore, as they are zinc-dependent enzymes, their activity is inhibited by metal chelators like dipicolinic acid or EDTA. ESBLs (A) do not hydrolyze carbapenems. KPC (B) and OXA-48 (C) are serine-based enzymes not inhibited by chelators, and KPC readily hydrolyzes aztreonam.
- A microbiologist is investigating resistance mechanisms in a variety of clinical isolates. For which antibiotic-organism pair is enzymatic degradation of the drug LEAST likely to be the primary mechanism of resistance?
Answer: Erythromycin resistance in Streptococcus pneumoniae
While several mechanisms can contribute, the most common and clinically significant form of high-level macrolide (e.g., erythromycin) resistance in Gram-positive cocci like Streptococcus pneumoniae is target site modification. This is mediated by an Erm methylase, which dimethylates an adenine residue in the 23S rRNA, preventing the drug from binding to the ribosome. In contrast, penicillinase (B), aminoglycoside-modifying enzymes (A), and carbapenemases (D) are all very common and primary mechanisms of enzymatic drug degradation for their respective drug-organism pairs.
- What is the most likely explanation for the development of this resistance profile?
Answer: Selection of a subpopulation with a stable derepressed AmpC beta-lactamase.
Enterobacter species possess an inducible chromosomal AmpC beta-lactamase. Treatment with potent inducers like third-generation cephalosporins (e.g., ceftriaxone) can select for mutants that constitutively overexpress (derepress) AmpC. This results in resistance to most penicillins and cephalosporins, including beta-lactamase inhibitor combinations like piperacillin-tazobactam. Continued susceptibility to imipenem makes a carbapenemase (D) unlikely. Resistance to piperacillin-tazobactam makes a typical ESBL (A) less likely than derepressed AmpC.
- The enzymatic activity of beta-lactamase involves hydrolysis of the amide bond within the four-membered beta-lactam ring. What structural feature of this ring makes this bond particularly susceptible to hydrolysis compared to a typical linear amide?
Answer: Significant geometric ring strain forces the amide bond to be non-planar, increasing its reactivity.
The primary reason for the high reactivity of the beta-lactam amide bond is ring strain. In a stable, linear amide, the nitrogen atom's lone pair of electrons delocalizes into the carbonyl group, creating resonance stabilization and a planar geometry. The geometric constraints of the small, four-membered ring prevent this ideal planarity and resonance. This makes the carbonyl carbon more electrophilic (more ketone-like) and the amide bond weaker, rendering it highly susceptible to nucleophilic attack by the beta-lactamase enzyme.
- Vaborbactam is a non-beta-lactam beta-lactamase inhibitor that utilizes a boronic acid moiety and is highly effective against KPC-type carbapenemases. What is the primary mechanism by which vaborbactam inhibits serine beta-lactamases like KPC?
Answer: It forms a stable, reversible covalent bond with the active site serine residue, mimicking the hydrolysis transition state.
Boronic acid inhibitors like vaborbactam work by forming a dative covalent bond between the boron atom and the hydroxyl oxygen of the active site serine residue in serine beta-lactamases (like KPC). This complex is very stable and mimics the tetrahedral transition state of beta-lactam hydrolysis, effectively trapping the enzyme in an inactive form. The inhibition is covalent but typically reversible. It does not chelate zinc (A), as KPC is a serine, not metallo, enzyme. It is an active-site inhibitor, not allosteric (C). Its mechanism is distinct from suicide inhibitors like clavulanate (D).
- A carbapenem-resistant Enterobacter cloacae isolate is found to have a mutation leading to the loss of a major outer membrane porin channel. Additionally, it expresses its chromosomal AmpC beta-lactamase at basal, uninduced levels. What is the most likely role of the AmpC enzyme in this isolate's carbapenem resistance?
Answer: Porin loss reduces the rate of carbapenem entry, allowing the weak intrinsic carbapenemase activity of AmpC to be effective.
This is a classic example of synergistic resistance. Wild-type AmpC has very poor hydrolytic activity against carbapenems. Porin loss alone typically only causes a small increase in the carbapenem MIC. However, when combined, the two mechanisms lead to clinical resistance. The porin loss acts as a barrier, slowing the influx of carbapenem into the periplasmic space. This reduced rate of entry allows the low-level but present AmpC enzyme sufficient time to hydrolyze the few drug molecules that do enter, preventing them from reaching their PBP targets.
